Ptc Therapeutics (PTCT) Treasury Shares (2012 - 2026)

Ptc Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• On a quarterly basis, Treasury Shares fell 6.66% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $3.6 million, a 6.66% decrease from a year earlier, with the FY2025 full-year figure at $25000.0, down 87.88% from the prior year.
• Treasury Shares improved to $3.6 million in Q1 2026 per PTCT's latest filing, from $25000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $3.9 million in Q1 2025 and bottomed at $25000.0 in Q4 2025.
• The 5-year median for Treasury Shares is $3.6 million (2024), against an average of $2.9 million.
• Across the five-year window, Treasury Shares soared 68.27% in 2022 and tumbled 92.8% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $2.5 million in 2022, then climbed by 13.91% to $2.9 million in 2023, then tumbled by 92.8% to $206250.0 in 2024, then plunged by 87.88% to $25000.0 in 2025, then jumped by 14360.7% to $3.6 million in 2026.
• Per Business Quant, the three latest PTCT Treasury Shares figures stand at $3.6 million (Q1 2026), $25000.0 (Q4 2025), and $3.8 million (Q3 2025).